| 前收市價 | 30.45 |
| 開市 | 40.00 |
| 買盤 | 39.60 |
| 賣出價 | 42.80 |
| 拍板 | 910.00 |
| 到期日 | 2024-08-09 |
| 今日波幅 | 39.50 - 41.70 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 33 |
Investor's Business DailyStock Market: S&P 500, Nasdaq Hit Highs As Tesla Soars, Rate-Cut Hopes Rise: Weekly Review
Tesla drove the S&P 500 and Nasdaq to highs, though small caps fell for the week. Cooling economic data raised rate-cut hopes.
ZacksPharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Eli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi (SNY) and Regeneron's Dupixent gets approval for COPD in Europe.
Motley FoolMissed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio
Could Zealand Pharma be a better option for growth-oriented investors?
